日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nanobodies and their derivatives: pioneering the future of cancer immunotherapy

纳米抗体及其衍生物:引领癌症免疫疗法的未来

Li, Haixia; Zhou, Quan; Cao, Nan; Hu, Chenghao; Wang, Jincheng; He, Yu; Jiang, Shan; Li, Qi; Chen, Miao; Gong, Li; Luo, Ming; Deng, Xinzhou; Luo, Zhiguo

Correction: Case Report: The integration of chemoradiotherapy and immunotherapy in a patient with advanced-stage renal squamous cell carcinoma and pulmonary metastases

更正:病例报告:化疗放疗联合免疫疗法治疗晚期肾鳞状细胞癌伴肺转移患者

Niu, Yanlin; Wang, Shengchao; Deng, Xinzhou; Luo, Ming; Chai, Jingjing; Luo, Zhiguo

Case Report: The integration of chemoradiotherapy and immunotherapy in a patient with advanced-stage renal squamous cell carcinoma and pulmonary metastases

病例报告:化疗放疗联合免疫疗法治疗晚期肾鳞状细胞癌肺转移患者

Niu, Yanlin; Wang, Shengchao; Deng, Xinzhou; Luo, Ming; Chai, Jingjing; Luo, Zhiguo

A lectin-based glycomic approach identifies FUT8 as a driver of radioresistance in oesophageal squamous cell carcinoma.

基于凝集素的糖组学方法发现 FUT8 是食管鳞状细胞癌放射抗性的驱动因素。

Shen Li, Xia Min, Deng Xinzhou, Ke Qing, Zhang Chuanyi, Peng Feng, Dong Xiaoxia, Luo Zhiguo

Bioinformatics analysis of the prognostic value of Tripartite Motif 28 in breast cancer

利用生物信息学分析三方基序28在乳腺癌中的预后价值

Hao, Ling; Leng, Jun; Xiao, Ruijing; Kingsley, Tembo; Li, Xinran; Tu, Zhenbo; Yang, Xiangyong; Deng, Xinzhou; Xiong, Meng; Xiong, Jie; Zhang, Qiuping

CCR9 in cancer: oncogenic role and therapeutic targeting

CCR9在癌症中的作用:致癌机制及治疗靶点

Tu, Zhenbo; Xiao, Ruijing; Xiong, Jie; Tembo, Kingsley M; Deng, Xinzhou; Xiong, Meng; Liu, Pan; Wang, Meng; Zhang, Qiuping